FDA inspection
Pendergrass, Dr Kelly B: FDA inspection ending Jul 25, 2002
FDA inspection 226218 · No Action Indicated (NAI) · Kansas City, MO
Key facts
| Inspection ID | 226218 |
|---|---|
| Firm | Pendergrass, Dr Kelly B |
| FEI number | 1000118420 |
| Address | 6420 Prospect Ave Ste T101 |
| City | Kansas City |
| State | MO |
| ZIP | 64132-4147 |
| Fiscal year | 2002 |
| Inspection end date | Jul 25, 2002 |
| Classification | No Action Indicated (NAI) |
| Project area | Bio-Research Monit: Human Drugs |
| Product type | Drugs |
At a glance
- None Citations
- None Posted citations
- No Warning letter followed
- Yes Form FDA 483 issued
- No Establishment inspection report (EIR) exists
- 1–9 Inspections at this FEI
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About FDA inspections
FDA inspections are classified as No Action Indicated (NAI), Voluntary Action Indicated (VAI) or Official Action Indicated (OAI). Inspections of individual clinical investigators are not published here.
Source: U.S. Food and Drug Administration (FDA), inspection classification data